Streetbeat News

Stock Prices

AWF

Alliancebernstein Glb (NYSE:AWF) has announced a monthly dividend of 6.55 cents per share, with Wednesday being the last day for investors to buy the stock and be eligible for the dividend. The stock will go ex-dividend on Thursday, meaning it will trade lower by the dividend amount. The dividend is scheduled to be paid on December 22, 2023.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:45 pm

LILA

MOMO

TEO

Benzinga Insights identifies value stocks in the communication services sector based on low P/E ratios. Stocks mentioned include Verizon Communications (VZ), Liberty Latin America (LILA), Hello Gr (MOMO), Telecom Argentina (TEO), and KT (KT). Verizon's EPS increased slightly in Q3, and its dividend yield rose. Liberty Latin America, Hello Gr, and Telecom Argentina also reported increases in EPS, while KT's EPS grew from Q1 to Q2. Value stocks may take time to rebound and carry the risk of not doing so.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:45 pm

AFB

Alliancebernstein (NYSE:AFB) announced a monthly dividend of 3.27 cents per share, with Wednesday being the last day for investors to be eligible for the dividend. The stock will go ex-dividend on Thursday, meaning it will likely open 3.27 cents lower to reflect the payout. Shareholders owning AFB by the end of Wednesday will receive the dividend on December 22, 2023.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:45 pm

MNRO

Monro (NASDAQ:MNRO) has announced a quarterly dividend of 28 cents per share, with Wednesday being the last day for investors to buy the stock and be eligible for the dividend. The stock will go ex-dividend on Thursday, meaning it will likely open 28 cents lower. The dividend is scheduled to be paid on December 19, 2023.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:45 pm

EFC

Ellington Financial (NYSE:EFC) announced a monthly dividend of 6 cents per share, with the ex-dividend date set for Thursday. Shareholders owning the stock by the end of Wednesday are eligible for the dividend, which will be paid on December 13, 2023. The stock is expected to open 6 cents lower on the ex-dividend date.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:45 pm

EXC

Exelon Inc. (NASDAQ:EXC) has seen a 0.26% decrease in its stock price in the current session, trading at $38.89. Over the past month and year, the stock has fallen by 2.57% and 9.68%, respectively. Exelon's P/E ratio of 18.13 is lower than the Electric Utilities industry average of 22.23, which could suggest the stock is undervalued or expected to underperform. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:45 pm

ARCT

CCRN

PRE

SPRO

ZYME

The article identifies five value stocks in the healthcare sector based on their low price-to-earnings (P/E) multiples, suggesting they may be undervalued. The stocks mentioned are Cross Country Healthcare (CCRN), Prenetics Global (PRE), Spero Therapeutics (SPRO), Arcturus Therapeutics (ARCT), and Zymeworks (ZYME). The article also provides recent changes in earnings per share for these companies and notes the risks associated with investing in value stocks.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:44 pm

ABR

AFCG

FPH

RITM

SEVN

Benzinga Insights identifies value stocks in the real estate sector based on low P/E ratios. AFC Gamma (AFCG), Arbor Realty Trust (ABR), Rithm Capital (RITM), Five Point Holdings (FPH), and Seven Hills Realty Trust (SEVN) are highlighted for their undervaluation. The article provides recent EPS and dividend yield changes for these companies, suggesting potential investment opportunities.

Portfolio Pulse from Benzinga Insights

December 04, 2023 | 2:39 pm

SSNT

SilverSun Technologies shares resumed trading after a circuit breaker halt. The halt was triggered due to significant volatility in the stock's price.

Portfolio Pulse from Benzinga Newsdesk

December 04, 2023 | 2:38 pm

VALN

Valneva SE reported that 24 months after vaccination with a single dose of its chikungunya vaccine IXCHIQ, 97% of participants retained neutralizing antibodies. The vaccine was FDA approved in November 2023. The data supports long-term durability and supplements existing FDA approval and ongoing regulatory processes. No safety concerns were identified, and EMA and Health Canada are reviewing marketing applications. Valneva's stock (VALN) is down 3.69% at $11.08.

Portfolio Pulse from Vandana Singh

December 04, 2023 | 2:34 pm